Leberregenierung

European patent · EP2637683 · In force

Register entry

Publication number
EP2637683
Application number
EP11839627
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 9, 2011
Published
Sep 18, 2013
Granted
Mar 4, 2020
Protection ends at the latest
Nov 8, 2031
Next annual fee due
Nov 30, 2026
IPC classes
A61K 38/18 (2006.01)
A61K 35/12 (2015.01)
A61K 48/00 (2006.01)
A61K 39/395 (2006.01)
A61P 1/16 (2006.01)
Priority
US 201161545851 P 11.10.2011
US 411732 P 09.11.2010
PCT application
PCT/US2011/059960 09.11.2011
PCT publication
WO2012/064834 18.05.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  5. Apr 30, 2020

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 30.04.2020

  6. Mar 4, 2020

    Granted

    Published in Swissreg on 04.03.2020

Parties

Holder

Cornell University

Cornell Center for Technology Enterprise & Commercialization 395 Pine Tree Road Suite 310, Ithaca, NY 14850, US

Agent

Bovard AG

BOVARD AG Patent- und Markenanwälte

Optingenstrasse 16, 3013 Bern

Inventor

RAFII, Shahin

New York New York 10021, US

DING, Bi-Sen

Bloomfield New Jersey 07003, US

RABBANY, Sina Y.

Great Neck New York 11021, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.